• Principal Investigator
  • Male

Dr. J.W. Ganzevoort MD PhD

Position: Scientific staff member (UD)
Main activities: Patient care
Specialisation: Gynecologist, Perinatologist
foto J.W. Ganzevoort is one of the AMC Principal Investigators
Focus of research:

Hypertensive disorders of pregnancy (preeclampsia, HELLP-syndrome): management during pregnancy; recurrence risks in next pregnancies; long-term (vascular) morbidity; 

Diagnosis and management of Fetal growth Restriction

AMC themes: Reproduction and development
Departments: Obstetrics and Gynaecology
Beukers F, Aarnoudse-Moens CSH, van Weissenbruch MM, Ganzevoort W, van Goudoever JB, van Wassenaer-Leemhuis AG, Fetal Growth Restriction with Brain Sparing: Neurocognitive and Behavioral Outcomes at 12 Years of Age. J PEDIATR-US 2017;188:103-+ [PubMed]
Beukers F, Rotteveel J, van Weissenbruch MM, Ganzevoort W, van Goudoever JB, van Wassenaer-Leemhuis AG, Growth throughout childhood of children born growth restricted. ARCH DIS CHILD 2017;102 (8):735-741 [PubMed]
Bilardo CM, Hecher K, Visser GHA, Papageorghiou AT, Marlow N, Thilaganathan B, van Wassenaer-Leemhuis A, Todros T, Marsal K, Frusca T, Arabin B, Brezinka C, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Ganzevoort W, Martinelli P, Ostermayer E, Schlembach D, Valensise H, Thornton J, Wolf H, Lees C [Contributors: Calda P, Gordjin S, Gyselaers W, Klaritsch P, Lobmaier S, Manz M, Napolitano R, Prefumo F, Schild R, Stampalija T, von Holsbeke C, von Kaisenberg C]] , Severe fetal growth restriction at 26-32 weeks: key messages from the TRUFFLE study. ULTRASOUND OBST GYN 2017;50 (3):285-290 [PubMed]
Bokslag A, Teunissen PW, Franssen C, van Kesteren F, Kamp O, Ganzevoort W, Paulus WJ, de Groot CJM, Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life. AM J OBSTET GYNECOL 2017;216 (5):523.e1-523.e7 [PubMed]
Ganzevoort W, Mensing van Charante N, Thilaganathan B, Prefumo F, Arabin B, Bilardo CM, Brezinka C, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Frusca T, Hecher K, Marlow N, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KTM, Todros T, Valcamonico A, Visser GHA, van Wassenaer-Leemhuis A, Lees CC, Wolf H [Contributors: Aktas A, Borgione S, Chaoui R, Cornette JMJ, Diehl T, van Eyck J, Fratelli N, van Haastert IC, Lobmaier S, Lopriore E, Missfelder-Lobos H, Mansi G, Martelli P, Maso G, Maurer-Fellbaum U, Mulder-de Tollenaer S, Napolitano R, Oberto M, Oepkes D, Ogge G, van der Post JAM, Preston L, Raimondi F, Rattue H, Reiss IKM, Scheepers LS, Skabar A, Spaanderman M, Weisglas-Kuperus N, Zimmermann A]] , How to monitor pregnancies complicated by fetal growth restriction and delivery before 32 weeks: post-hoc analysis of TRUFFLE study. ULTRASOUND OBST GYN 2017;49 (6):769-777 [PubMed]
Groom KM, McCowan LM, Mackay LK, Lee AC, Said JM, Kane SC, Walker SP, van Mens TE, Hannan NJ, Tong S, Chamley LW, Stone PR, McLintock C [Contributors: Groom K, McCowan L, Mackay L, Lee A, Stone P, Chamley L, McLintock C, Said J, Kane S, Walker S, Tong S, Hannan N, van Mens T, Ganzevoort W, Middeldorp S]] , Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial. AM J OBSTET GYNECOL 2017;216 (3):296.e1-296.e14 [PubMed]
Knaven O, Ganzevoort W, de Boer M, Wolf H, Fetal heart rate variation after corticosteroids for fetal maturation. EUR J OBSTET GYN R B 2017;216:38-45 [PubMed]
Paauw ND, Terstappen F, Ganzevoort W, Joles JA, Gremmels H, Lely AT, Sildenafil During Pregnancy A Preclinical Meta-Analysis on Fetal Growth and Maternal Blood Pressure. HYPERTENSION 2017;70 (5):998-+ [PubMed]
Stampalija T, Arabin B, Wolf H, Bilardo CM, Lees C [Contributors: Brezinka C, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Frusca T, Ganzevoort W, Hecher K, Kingdom J, Marlow N, Marsal K, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KTM, Thilaganathan B, Thornton J, Todros T, Valcamonico A, Valensise H, van Wassenaer-Leemhuis A, Visser GHA, Aktas A, Borgione S, Chaoui R, Cornette JMJ, Diehl T, van Eyck J, Fratelli N, van Haastert IC, Lobmaier S, Lopriore E, Missfelder-Lobos H, Mansi G, Martelli P, Maso G, Maurer-Fellbaum U, Mensing van Charante N, Mulder-de Tollenaer S, Napolitano R, Oberto M, Oepkes D, Ogge G, van der Post JAM, Prefumo F, Preston L, Raimondi F, Reiss IKM, Scheepers LS, Skabar A, Spaanderman M, Weisglas-Kuperus N, Zimmermann A]] , Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction?. AM J OBSTET GYNECOL 2017;216 (5):521.e1-521.e13 [PubMed]
Thangaratinam S, Allotey J, Marlin N, Dodds J, Cheong-See F, von Dadelszen P, Ganzevoort W, Akkermans J, Kerry S, Mol BW, Moons KGM, Riley RD, Khan KS [Contributors: Sundararajah R, Nejad A, Khan R, Burrell C, Gupta M, Oon V, Kadir R, Ramsey-Marcelle Z, Page L, Thilaganathan B, Martin B, Bakour SH, Morsi H, Churchill D, O'Mahony F, Powell K, Srinivasan J, Mohajer M, Quenby S, Thirumalaikumar L, Konje J, Thornton J, Bugg G, Mackenzie S, Ullal A, Smith M, Arya R, Cunnigham S, Walker J, Simpson N, Page J, Oxby C, Watkins K, Tuffnell D, Bober S, Wijesiriwardana A, Brandon H, El-Badawy S, Brigham S, Shorinola L, Khunda A, Kalla S, Agha MMA, Poku S, Olawo A, Amu J, Banfield P, Majoko F, Alcide J, Rajeswary J, Salloum M, Rees A, Oteri O, Ikhena S, Creswell J, Dawood F, Agarwal U]] , Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models. BMC MED 2017;15 (1):68 [PubMed]
Thangaratinam S, Allotey J, Marlin N, Mol BW, von Dadelszen P, Ganzevoort W, Akkermans J, Ahmed A, Daniels J, Deeks J, Ismail K, Barnard AM, Dodds J, Kerry S, Moons C, Riley RD, Khan KS, Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study. HEALTH TECHNOL ASSES 2017;21 (18):1-100 [PubMed]
van Baaren GJ, Broekhuijsen K, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KWM, Scheepers HCJ, Bremer HA, Rijnders RJP, van Loon AJ, Perquin DAM, Sporken JMJ, Papatsonis DNM, van Huizen ME, Vredevoogd CB, Brons JTJ, Kaplan M, van Kaam AH, Groen H, Porath M, van den Berg PP, Mol BWJ, Franssen MTM, Langenveld J, An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II). BJOG-INT J OBSTET GY 2017;124 (3):453-461 [PubMed]
van Oostwaard MF, van Eerden L, de Laat MW, Duvekot JJ, Erwich JJHM, Bloemenkamp KWM, Bolte AC, Bosma JPF, Koenen SV, Kornelisse RF, Rethans B, van Runnard Heimel P, Scheepers HCJ, Ganzevoort W, Mol BWJ, de Groot CJ, Gaugler-Senden IPM, Maternal and neonatal outcomes in women with severe early onset pre-eclampsia before 26 weeks of gestation, a case series. BJOG-INT J OBSTET GY 2017;124 (9):1440-1447 [PubMed]
Verbrugge LNH, Ganzevoort W, Fliervoet JM, Panten K, van den Born RJG, Implementing participatory monitoring in river management: The role of stakeholders' perspectives and incentives. J ENVIRON MANAGE 2017;195 (1):62-69 [PubMed]
Visser GHA, Bilardo CM, Derks JB, Ferrazzi E, Fratelli N, Frusca T, Ganzevoort W, Lees CC, Napolitano R, Todros T, Wolf H, Hecher K [Contributors: Marlow N, Arabin B, Brezinka C, Diemert A, Duvekot JJ, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider K, Thilaganathan B, Valcamonico A]] , Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study. ULTRASOUND OBST GYN 2017;50 (3):347-352 [PubMed]
Wolf H, Arabin B, Lees CC, Oepkes D, Prefumo F, Thilaganathan B, Todros T, Visser GHA, Bilardo CM, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Frusca T, Hecher K, Marlow N, Martinelli P, Ostermayer E, Papageorghiou AT, Scheepers HCJ, Schlembach D, Schneider KTM, Valcamonico A, van Wassenaer-Leemhuis A, Ganzevoort W [Contributors: Aktas A, Borgione S, Brezinka C, Calvert S, Chaoui R, Cornette JMJ, Diehl T, van Eyck J, Fratelli N, van Haastert IL, Johnson S, Lobmaier S, Lopriore E, Mansi G, Missfelder-Lobos H, Martelli P, Maso G, Maurer-Fellbaum U, van Charante NM, de Tollenaer SM, Moore T, Napolitano R, Oberto M, Ogge G, van der Post J, Preston L, Raimondi F, Reiss IKM, Rigano S, Schuit E, Skabar A, Spaanderman M, Weisglas-Kuperus N, Zimmermann A]] , Longitudinal study of computerized cardiotocography in early fetal growth restriction. ULTRASOUND OBST GYN 2017;50 (1):71-78 [PubMed]
Zwertbroek EF, Broekhuijsen K, Langenveld J, van Baaren GJ, van den Berg PP, Bremer HA, Ganzevoort W, van Loon AJ, Mol BWJ, van Pampus MG, Perquin DAM, Rijnders RJP, Scheepers HCJ, Sikkema MJ, Woiski MD, Groen H, Franssen MTM, Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy. ACTA OBSTET GYN SCAN 2017;96 (1):96-105 [PubMed]
Ahmed RJ, Gafni A, Hutton EK, Hu ZJ, Pullenayegum E, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez JJ, Ganzevoort W, Helewa M, Lee SK, Lee T, Logan AG, Moutquin JM, Singer J, Thornton JG, Welch R, Magee LA, The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial). HYPERTENSION 2016;68 (4):1049-1055 [PubMed]
Bleker SM, Buchmüller A, Chauleur C, Ní Áinle F, Donnelly J, Verhamme P, Jacobsen AF, Ganzevoort W, Prins M, Beyer-Westendorf J, DeSancho M, Konstantinides S, Pabinger I, Rodger M, Decousus H, Middeldorp S, Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses. THROMB RES 2016;144:62-68 [PubMed]
Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W, Consensus definition of fetal growth restriction: a Delphi procedure. ULTRASOUND OBST GYN 2016;48 (3):333-339 [PubMed]
Lobmaier SM, Mensing van Charante N, Ferrazzi E, Giussani DA, Shaw CJ, Müller A, Ortiz JU, Ostermayer E, Haller B, Prefumo F, Frusca T, Hecher K, Arabin B, Thilaganathan B, Papageorghiou AT, Bhide A, Martinelli P, Duvekot JJ, van Eyck J, Visser GHA, Schmidt G, Ganzevoort W, Lees CC, Schneider KTM [Contributors: Bilardo CM, Brezinka C, Diemert A, Derks JB, Schlembach D, Todros T, Valcamonico A, Marlow N, van Wassenaer-Leemhuis A]] , Phase-rectified signal averaging method to predict perinatal outcome in infants with very preterm fetal growth restriction- a secondary analysis of TRUFFLE-trial. AM J OBSTET GYNECOL 2016;215 (5):630.e1-630.e7 [PubMed]
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM, Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?. BJOG-INT J OBSTET GY 2016;123 (7):1135-1141 [PubMed]
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM, Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG-INT J OBSTET GY 2016;123 (7):1143-1151 [PubMed]
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM, Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial. ACTA OBSTET GYN SCAN 2016;95 (7):763-776 [PubMed]
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM, The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?. HYPERTENSION 2016;68 (5):1153-1159 [PubMed]
van Kuijk SM, Delahaije DH, Dirksen CD, Scheepers HC, Spaanderman ME, Ganzevoort W, Duvekot JJ, Oudijk MA, van Pampus MG, Peeters LL, Smits LJ, Multicenter impact analysis of a model for predicting recurrent early-onset preeclampsia: A before-after study. HYPERTENS PREGNANCY 2016;35 (1):42-54 [PubMed]
Vidler M, Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM, Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study). EUR J OBSTET GYN R B 2016;206:105-113 [PubMed]
Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KWM, Scheepers HCJ, Bremer HA, Rijnders RJP, van Loon AJ, Perquin DAM, Sporken JMJ, Papatsonis DNM, van Huizen ME, Vredevoogd CB, Brons JTJ, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BWJ, Franssen MTM, Langenveld J, Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial. OBSTET GYNECOL SURV 2015;70 (10):605-607
Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KWM, Scheepers HCJ, Bremer HA, Rijnders RJP, van Loon AJ, Perquin DAM, Sporken JMJ, Papatsonis DNM, van Huizen ME, Vredevoogd CB, Brons JTJ, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BWJ, Franssen MTM, Langenveld J [Contributors: Ganzevoort W, van der Akker ESA, Fong CB, Hummel P, Muller MA, Bax C, Hermsen BBJ, Hemelaar M, Kleiverda G, Doekhie B, Visser H, Pernet PJM, Mozes A, van Zandvoort H, van Beek E, Kwee A, Oudijk MA, Huisjes AJM, Zanders EHJ, Schuitemaker NWE, Deurlo K, Evers I, Bloemenkamp KWM, van Meir CA, Vredevoogd CB, van Huizen ME, van Unnik GA, Porath MM, van Oirschot CM, Rijnders RJP, Scheepers LCJ, Langenveld J, Roumen F, Wijnen EJ, Aardenburg R, Franssen MTM, van Loon AJ, Perquin D, Koops A, Bremer HA, Papatsonis DNM, van Gemund N, Akerboom BMC, Smid-Koopman E, de Boer K, Woiski MD, Sporken JMJ, de Wit AC, van Ginkel AA, Verhagen TEM, Stigter RH, Brons JTJ, Sikkema JM, Kaplan M]] , Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. LANCET 2015;385 (9986):2492-2501 [PubMed]
Lees CC, Marlow N, van Wassenaer-Leemhuis A, Arabin B, Bilardo CM, Brezinka C, Calvert S, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Frusca T, Ganzevoort W, Hecher K, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KTM, Thilaganathan B, Todros T, Valcamonico A, Visser GHA, Wolf H, 2 Year Neurodevelopmental and Intermediate Perinatal Outcomes in Infants With Very Preterm Fetal Growth Restriction (TRUFFLE): A Randomised Trial. OBSTET GYNECOL SURV 2015;70 (9):555-557
Lees CC, Marlow N, van Wassenaer-Leemhuis A, Arabin B, Bilardo CM, Brezinka C, Calvert S, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Frusca T, Ganzevoort W, Hecher K, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KTM, Thilaganathan B, Todros T, Valcamonico A, Visser GHA, Wolf H [Contributors: Aktas A, Borgione S, Chaoui R, Cornette JMJ, Diehl T, van Eyck J, Fratelli N, van Haastert IL, Lobmaier S, Lopriore E, Missfelder-Lobos H, Mansi G, Martelli P, Maso G, Maurer-Fellbaum U, van Charante NM, de Tollenaer SM, Napolitano R, Oberto M, Oepkes D, Ogge G, van der Post J, Prefumo F, Preston L, Raimondi F, Reiss IKM, Scheepers HCJ, Schuit E, Center J, Skabar A, Spaanderman M, Weisglas-Kuperus N, Zimmermann A, Moore T, Johnson S, Rigano S]] , 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. LANCET 2015;385 (9983):2162-2172 [PubMed]
Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM, Less-Tight versus Tight Control of Hypertension in Pregnancy. NEW ENGL J MED 2015;372 (5):407-417 [PubMed]
Pels A, Ganzevoort W, Safety and Efficacy of Ferric Carboxymaltose in Anemic Pregnant Women: A Retrospective Case Control Study. OBSTET GYNECOL INT 2015;2015:728952 [PubMed]
Schokker SAM, van Oostwaard MF, Melman EM, van Kessel JP, Baharoglu MI , Roos YBWEM, Vogt L, de Winter RJ, Mol BW, Ganzevoort W, Cerebrovascular, cardiovascular and renal hypertensive disease after hypertensive disorders of pregnancy. PREGNANCY HYPERTENS 2015;5 (4):287-293 [PubMed]
van Oostwaard MF. Counseling women with hypertensive disorders of pregnancy. S.l.: s.n.; 2015. 216p. ISBN 978-90-6464-944-8 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Mol BWJ, Steegers EAP; copromotor(s): Ganzevoort W, Papatsonis DNM)
van Oostwaard MF, Langenveld J, Schuit E, Papatsonis DNM, Brown MA, Byaruhanga RN, Bhattacharya S, Campbell DM, Chappell LC, Chiaffarino F, Crippa I, Facchinetti F, Ferrazzani S, Ferrazzi E, Figueiró-Filho EA, Gaugler-Senden IPM, Haavaldsen C, Lykke JA, Mbah AK, Oliveira VM, Poston L, Redman CWG, Salim R, Thilaganathan B, Vergani P, Zhang J, Steegers EAP, Mol BWJ, Ganzevoort W, Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. AM J OBSTET GYNECOL 2015;212 (5):624.e1-624.17 [PubMed]
Akkermans J, Payne B, von Dadelszen P, Groen H, Vries Jd, Magee LA, Mol BW, Ganzevoort W, Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset. EUR J OBSTET GYN R B 2014;179:58-62 [PubMed]
Delahaije DHJ, Smits LJM, van Kuijk SMJ, Peeters LL, Duvekot JJ, Ganzevoort W, Oudijk MA, van Pampus MG, Scheepers HCJ, Spaanderman ME, Dirksen CD, Care-as-usual provided to formerly preeclamptic women in the Netherlands in the next pregnancy: health care consumption, costs and maternal and child outcome. EUR J OBSTET GYN R B 2014;179:240-245 [PubMed]
Ganzevoort W, Alfirevic Z, von Dadelszen P, Kenny L, Papageorghiou A, van Wassenaer-Leemhuis A, Gluud C, Mol BW, Baker PN, STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis. SYST REV 2014;3 (1):23 [PubMed]
Lees C [Contributors: Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, Duvekot J, Frusca T, Diemert A, Ferrazzi E, Ganzevoort W, Hecher K, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KT, Thilaganathan B, Todros T, van Wassenaer-Leemhuis A, Valcamonico A, Visser GH, Wolf H]] , Should not the terms 'width', 'depth' and 'length' be used in accordance with anatomical planes? Reply. ULTRASOUND OBST GYN 2014;43 (2):237-238 [PubMed]
van Kuijk SM, Delahaije DH, Dirksen CD, Scheepers HC, Spaanderman ME, Ganzevoort W, Duvekot JJ, Oudijk MA, van Pampus MG, von Dadelszen P, Peeters LL, Smits LJ, External validation of a model for periconceptional prediction of recurrent early-onset preeclampsia. HYPERTENS PREGNANCY 2014;33 (3):265-276 [PubMed]
van Oostwaard MF, Langenveld J, Schuit E, Wigny K, van Susante H, Beune I, Ramaekers R, Papatsonis DNM, Mol BWJ, Ganzevoort W, Prediction of recurrence of hypertensive disorders of pregnancy in the term period, a retrospective cohort study. PREGNANCY HYPERTENS 2014;4 (3):194-202 [PubMed]
Voskamp BJ, Kazemier BM, Schuit E, Mol BWJ, Buimer M, Pajkrt E, Ganzevoort W, Birth weight ratio as an alternative to birth weight percentile to express infant weight in research and clinical practice: a nationwide cohort study. OBSTET GYNECOL INT 2014;2014:749476 [PubMed]
Beukers F, Cranendonk A, de Vries JIP, Wolf H, Lafeber HN, Vriesendorp HC, Ganzevoort W, van Wassenaer-Leemhuis AG, Catch-up growth in children born growth restricted to mothers with hypertensive disorders of pregnancy. ARCH DIS CHILD 2013;98 (1):30-35 [PubMed]
Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, Duvekot J, Frusca T, Diemert A, Ferrazzi E, Ganzevoort W, Hecher K, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KTM, Thilaganathan B, Todros T, van Wassenaer-Leemhuis A, Valcamonico A, Visser GHA, Wolf H [Contributors: Scheepers HCJ, Spaanderman M, Calvert S, Missfelder-Lobos H, van Eyck J, Oepkes D, Fratelli N, Prefumo F, Napolitano R, Chaoui R, Maso G, Ogge G, Oberto M, Mensing van Charante N]] , Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). ULTRASOUND OBST GYN 2013;42 (4):400-408 [PubMed]
[Contributors: Vink R, Ganzevoort W, van der Post J, de Pont ACJM]] , HELLP, een potentieel levensbedreigende aandoening. HUISARTS WET 2013;56:590-593
van Oostwaard MF, Langenveld J, Bijloo R, Wong KM, Scholten I, Loix S, Hukkelhoven CWPM, Vergouwe Y, Papatsonis DNM, Mol BWJ, Ganzevoort W, Herhaling hypertensieve aandoening tijdens zwangerschap*. NED TIJDSCHR GENEESKD 2012;156 (39):A5314 [PubMed]
van Oostwaard MF, Langenveld J, Bijloo R, Wong KM, Scholten I, Loix S, Hukkelhoven CWPM, Vergouwe Y, Papatsonis DNM, Mol BWJ, Ganzevoort W, Prediction of recurrence of hypertensive disorders of pregnancy between 34 and 37 weeks of gestation: a retrospective cohort study. BJOG-INT J OBSTET GY 2012;119 (7):840-847 [PubMed]
Ganzevoort W, Sibai BM, Temporising versus interventionist management (preterm and at term). BEST PRACT RES CL OB 2011;25 (4):463-476 [PubMed]
Langenveld J. Hypertensive disorders in pre-term pregnancy: management and long-term consequences. s.l.: s.n.; 2011. 179p. ISBN 9789090264042 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Mol BWJ, Saade GR; copromotor(s): Ganzevoort W)
Langenveld J, Buttinger A, van der Post J, Wolf H, Mol BW, Ganzevoort W, Recurrence risk and prediction of a delivery under 34 weeks of gestation after a history of a severe hypertensive disorder. BJOG-INT J OBSTET GY 2011;118 (5):589-595 [PubMed]
Langenveld J, Ravelli ACJ, van Kaam AH, van der Ham DP, van Pampus MG, Porath M, Mol BW, Ganzevoort W, Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37 weeks of gestation: a 7 year retrospective analysis of a national registry. AM J OBSTET GYNECOL 2011;205 (6):540.e1-540.e7 [PubMed]
Tajik P, Oude Rengerink K, Ganzevoort W, Zwinderman AH, Mol BW, Bossuyt PM, Prediction of pre-eclampsia complications. LANCET 2011;377 (9774):1313 [PubMed]
van Wassenaer AG, Westera J, van Schie PEM, Houtzager BA , Cranendonk A, de Groot L, Ganzevoort W, Wolf H, de Vries JIP, Outcome at 4.5 years of children born after expectant management of early-onset hypertensive disorders of pregnancy. AM J OBSTET GYNECOL 2011;204 (6):510.e1-510.e9 [PubMed]
Langenveld J, Jansen SX, van der Post J, Wolf H, Mol BW, Ganzevoort W, Recurrence Risk of a Delivery before 34 Weeks of Pregnancy Due to an Early Onset Hypertensive Disorder: A Systematic Review. AM J PERINAT 2010;27 (7):565-571 [PubMed]
Akkermans J, Diepeveen M, Ganzevoort W, van Montfrans GA, Westerhof BE, Wolf H, Continuous Non-Invasive Blood Pressure Monitoring, a Validation Study of Nexfin in a Pregnant Population. HYPERTENS PREGNANCY 2009;28 (2):230-242 [PubMed]
Kaspers AG, Rep A, Ganzevoort W, Wolf H, de Vries JIP, van Wassenaer AG, No association between maternal psychological symptoms and infant outcome after pregnancy complicated by early-onset hypertensive disorders. ACTA PAEDIATR 2009;98 (2):298-303 [PubMed]
van Leeuwen S, Ganzevoort W, Dermout S, PICO Bello: LNG-IUD en mammacarcinoom. NED TIJDSCHR OBSTET GYNAECOL 2009;- (06):191-192
Rep A, Ganzevoort W, van Wassenaer AG, Bonsel GJ, Wolf H, de Vries JIP, One-year infant outcome in women with early-onset hypertensive disorders of pregnancy. BJOG-INT J OBSTET GY 2008;115 (2):290-298 [PubMed]
van Schie PEM, Rep A, Ganzevoort W, de Groot L, Wolf H, van Wassenaer AG, de Vries JIP [Contributors: Bleker OP, Boer K, Bonsel GJ, Briët JM, Fetter WPF, Ganzevoort W, van Geijn HP, de Groot L, Joosten JHK, Kaspers AG, Kok JH, van der Post JAM, Rep A, Schaaf VAM, van Schie JIP, van Sonderen L, de Vries JIP, van Wassenaer AG, Westera J, Wolf H]] , General movements in infants born from mothers with early-onset hypertensive disorders of pregnancy in relation to one year's neurodevelopmental outcome. EARLY HUM DEV 2008;84 (9):605-611 [PubMed]
Ganzevoort JW. Plasma volume expansion in early-onset hypertensive disorders of pregnancy. Preeclampsia Eclampsia TRial Amsterdam (PETRA). s.l.: s.n.; 2007. 301p. ISBN 9789081179911 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van der Post JAM, Bonsel GJ; copromotor(s): Wolf H, de Vries JIP)
Ganzevoort W, Rep A, Bonsel GJ, de Vries JIP, Wolf H, Dynamics and incidence patterns of maternal complications in early-onset hypertension of pregnancy. BJOG-INT J OBSTET GY 2007;114 (6):741-750 [PubMed]
Ganzevoort W, Rep A, de Vries JI, Bonsel GJ, Wolf H, Petra-Investigators FT, Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy. HYPERTENS PREGNANCY 2007;26 (4):433-445 [PubMed]
Rep A, Ganzevoort W, Bonsel GJ, Hans W, de Vries JIP, Psychosocial impact of early-onset hypertensive disorders and related complications in pregnancy. AM J OBSTET GYNECOL 2007;197 (2):e6-158.e6 [PubMed]
Ganzevoort W, Rep A, de Vries JIP, Bonsel GJ, Wolf H, Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. AM J OBSTET GYNECOL 2006;195 (2):495-503 [PubMed]
Metsaars WP, Ganzevoort W, Karemaker JM, Rang S, Wolf H, Increased sympathetic activity present in early hypertensive pregnancy is not lowered by plasma volume expansion. HYPERTENS PREGNANCY 2006;25 (3):143-157 [PubMed]
Buimer M, van Wassenaer AG, Ganzevoort W, Wolf H, Bleker OP, Kok JH, Transient hypothyroxinemia in severe hypertensive disorders of pregnancy. OBSTET GYNECOL 2005;106 (5 Part 1):973-979 [PubMed]
Ganzevoort W, Rep A, Bonsel GJ, Fetter WPF, van Sonderen L, de Vries JIP, Wolf H, A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. BJOG-INT J OBSTET GY 2005;112 (10):1358-1368 [PubMed]
Ganzevoort W, Rep A, Bonsel GJ, de Vries JIP, Wolf H, Plasma volume and blood pressure regulation in hypertensive pregnancy. J HYPERTENS 2004;22 (7):1235-1242 [PubMed]
Ganzevoort JW, Hoogerwaard EM, van der Post JAM, Hypocalciëmisch delier door magnesiumsulfaatbehandeling bij een zwangere met preëclampsie. NED TIJDSCHR GENEESKD 2002;146 (31):1453-1456 [PubMed]
Key publications

Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W, Consensus definition of fetal growth restriction: a Delphi procedure. ULTRASOUND OBST GYN 2016;48 (3):333-339 [PubMed]
van Oostwaard MF, Langenveld J, Schuit E, Papatsonis DNM, Brown MA, Byaruhanga RN, Bhattacharya S, Campbell DM, Chappell LC, Chiaffarino F, Crippa I, Facchinetti F, Ferrazzani S, Ferrazzi E, Figueiró-Filho EA, Gaugler-Senden IPM, Haavaldsen C, Lykke JA, Mbah AK, Oliveira VM, Poston L, Redman CWG, Salim R, Thilaganathan B, Vergani P, Zhang J, Steegers EAP, Mol BWJ, Ganzevoort W, Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. AM J OBSTET GYNECOL 2015;212 (5):624.e1-624.17 [PubMed]
Lees CC, Marlow N, van Wassenaer-Leemhuis A, Arabin B, Bilardo CM, Brezinka C, Calvert S, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Frusca T, Ganzevoort W, Hecher K, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KTM, Thilaganathan B, Todros T, Valcamonico A, Visser GHA, Wolf H [Contributors: Aktas A, Borgione S, Chaoui R, Cornette JMJ, Diehl T, van Eyck J, Fratelli N, van Haastert IL, Lobmaier S, Lopriore E, Missfelder-Lobos H, Mansi G, Martelli P, Maso G, Maurer-Fellbaum U, van Charante NM, de Tollenaer SM, Napolitano R, Oberto M, Oepkes D, Ogge G, van der Post J, Prefumo F, Preston L, Raimondi F, Reiss IKM, Scheepers HCJ, Schuit E, Center J, Skabar A, Spaanderman M, Weisglas-Kuperus N, Zimmermann A, Moore T, Johnson S, Rigano S]] , 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. LANCET 2015;385 (9983):2162-2172 [PubMed]
Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM, Less-Tight versus Tight Control of Hypertension in Pregnancy. NEW ENGL J MED 2015;372 (5):407-417 [PubMed]
Ganzevoort W, Alfirevic Z, von Dadelszen P, Kenny L, Papageorghiou A, van Wassenaer-Leemhuis A, Gluud C, Mol BW, Baker PN, STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis. SYST REV 2014;3 (1):23 [PubMed]


All Publications

Curriculum Vitae

Curriculum Vitae 

1999 Medical degree (cum laude); BIG-registration#: 39049404801
1999 - 2004 PhD-researcher, Dept. Obstetrics & Gynecology, Academisch Medisch Centrum (AMC), Universiteit van Amsterdam. Supervisor H. Wolf (AMC); Prof. Dr. JIP de Vries; “Preeclampsia Eclampsia TRial Amsterdam” Clinical trial on effects of plasma volume expansion on hemodynamics and clinical outcomes in patients with severe early-onset hypertensive disorders of pregnancy (preeclampsia, HELLP-syndrome, severe fetal growth restriction).
2004 - 2010 Resident Gynecology, Cluster AMC, Professor OP Bleker and Professor MJ Heineman; Spaarne Ziekenhuis Haarlem/Hoofddorp, MH Emanuel; Zaans Medisch Centrum (ZMC), H Doornbos;
07-09-2007 PhD-thesis Universiteit van Amsterdam. Promotores Prof. Dr. JAM van der Post & Prof. Dr. GJ Bonsel; Co-promotores Dr. H. Wolf & Prof. Dr. JIP de Vries. Title: Plasma volume expansion in early-onset hypertensive disorders of pregnancy
2010-2012 Gynecologist, Fellowship Perinatology, AMC
2012-present Gynecologist Perinatologist, AMC
 

Research projects involved

2000 - PETRA, RCT plasma volume expansion in temporising management of severe early-onset hypertensive disorders of pregnancy
2006 - Truffle, RCT in monitoring and intervention strategy in severe early fetal growth restriction
2007 - TOTEM, RCT immediate delivery versus temporising management of severe early-onset hypertensive disorders of pregnancy (Duvekot)
2008 - Glycocalyx in pre-eclampsia (Van den Born)
2009 - prediction modelling in recurrence of hypertensive disorders of pregnancy. Meta-analysis. Cohort studies and individual patient data meta-analysis.
2009 - CHIPS, RCT management of chronic hypertension in pregnancy (Magee)
2010 - Queen of hearts, hypertensive disorders of pregnancy and long-term cardiovascular risks: retrospective and prospective cohort studies (including planned intervention studies)
2013 - STRIDER, RCT sildenafil for severe early-onset FGR, main applicant
2017 - Dutch TRUFFLE, Cohort with nested RCT on early intervention (delivery) in children identified as FGR by abnormal Doppler studies within a group of SGA-children, main applicant
2013 - ObsEva, Phase 1-? Studies for new tocolytic drug
 

Courses followed

2008 Operatieve Verloskunde - Leiderdorp, NL
2009 NLS Provider Course - Riel, NL
2010 ISUOG Advanced Course Ultrasound in Obstetrics - London, UK
2010 ISSHP - Melbourne, Australia
2011 SMFM - San Francisco, USA
2011 MOET Provider Course - Riel, NL
2011 & 2012 & 2013 Teach The Teacher – Communication skills - Amsterdam, NL
 

Teaching positions

Member of team training residents Gynecology & Obstetrics, interns (co-assistenten).
Teacher at Amstel Academie for Obstetric Nursing  

Memberships

Organisations: NVOG, KNMG, ISSHP, ISUOG.
ICT-committee of the CPZ (College Perinatale Zorg)
Editor of the NTOG 

Research programmes

Placental disorders of Pregnancy: Fetal Growth Restriction and Hypertension

The program focuses on the maternal-fetal syndromes of placental insufficiency, the maternal including pre-eclampsia and HELLP-syndrome; the fetal including fetal growth restriction.

I am leading in international consensus procedures on nomenclature, international cooperation in the STRIDERproject (with five simultaneous RCTs) on treatment of FGR, TRUFFLE projects on diagnosis/monitoring/intervention in FGR.

Faculty
Dr. J.W. Ganzevoort MD PhD

PhD Students
Drs. A. Pels MD
M. Smies
Drs. I. Beune MD (UMCG)

Others
Drs. F. Beukers MD (Dept pediatrics AMC)
Drs. N.A. Mensing van Charante MD

Prof. dr. J.A.M. van der Post MD PhD (Reproductive Health, placental disease and maternal and fetal diseases)

Other research related activities
  • Contribution to guidelines and protocols, Landelijke richtlijn Foetale Groeirestrictie
  • Contribution to guidelines and protocols, Regioprotocol hypertensie in zwangerschap
  • Membership of editorial board / Editorship, NEDERLANDS TIJDSCHRIFT VOOR OBSTETRIE & GYNAECOLOGIE
  • Contribution to training of professionals, VU University Medical Center
  • Contribution to training of professionals, University of Amsterdam
  • Contribution to training of professionals, Amstel Academie
Current research funding
  • AMC
  • Crediteurenadm. VUmc, p/a Profource Service Center
  • University of British Columbia
  • ZonMw